GDRX Reddit Mentions

The company is modestly profitable on a per-share basis with EPS of 0.06, but the high PE ratio of 44.17 suggests the market is still pricing in meaningful future growth despite a challenged environment. Without detailed revenue and margin history, the combination of positive earnings and a rich multiple points to a business that has stabilized but is not yet demonstrating strong, accelerating profitability. Overall, the valuation looks demanding relative to current earnings power, keeping the outlook balanced rather than clearly positive.

• Positive EPS of 0.06 indicates the company is currently profitable, which is a constructive sign versus many early-stage or turnaround peers.
• A PE ratio of 44.17 is elevated relative to the broader market, implying investors are paying a premium for expected growth or improved margins that are not yet fully visible in current earnings.
• The high multiple against modest earnings suggests execution risk: if revenue growth or margin expansion disappoints, the stock could be vulnerable to downside repricing.

At $2.65, the stock trades below its 200-day moving average of $2.99, which is generally a sign of a longer-term downtrend or at least technical overhead resistance. However, the 14.7% gain over the last month shows improving short-term momentum and potential early signs of a base forming. Without an extreme overbought or oversold RSI provided, the mixed signals between short-term strength and longer-term weakness point to a neutral technical stance.

• Current price of $2.65 is below the 200-day moving average of $2.99, indicating the stock remains in a broader technical downtrend and may face resistance near the 200-day level.
• A 14.7% increase in the last month reflects improving near-term sentiment and buying interest, suggesting traders are starting to reassess downside risk.
• The combination of a sub-200-day price and recent rebound implies a consolidation or potential bottoming phase rather than a confirmed new uptrend.

Website traffic of roughly 21.6 million monthly visitors and 110,000 daily app downloads indicate a very large and active user base, which is strategically positive. However, app downloads are flat month over month and social media follower growth is very modest, suggesting user engagement and brand reach are stable rather than accelerating. Job openings up 25% month over month hint at selective investment and possible growth initiatives, but the scale (20 roles) is not large enough to strongly shift the outlook.

• High estimated web traffic (21.6M monthly visitors) and 110,000 daily app downloads confirm GoodRx retains substantial consumer reach and relevance in its category.
• App downloads are up 0.0% month over month and social follower growth across Twitter/X, Instagram, Facebook, and YouTube is low single-digit over 90 days, pointing to a plateau rather than strong growth in top-of-funnel demand.
• Job openings at 20, up 25% month over month, suggest the company is cautiously adding capacity or investing in new initiatives, but the modest absolute number indicates disciplined rather than aggressive expansion.

GoodRx shows signs of operational stability with positive EPS and a large, active user base, but the stock trades below its 200-day moving average and carries a high PE multiple that already embeds expectations for better growth and profitability. Alternative data signals point to a solid but not rapidly expanding platform, and recent stock price strength is still early relative to the longer-term downtrend. Overall, the balance of positives and risks supports a neutral stance on the stock at current levels.

• Profitability and strong user reach are positives, but the valuation (PE ~44) appears demanding given modest earnings and only stable, not accelerating, alternative data trends.
• Technical setup shows short-term improvement against a still-weak longer-term trend, leaving the risk/reward profile balanced rather than clearly bullish or bearish.